Critical Care
(Jul 2022)
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation
- Beatrijs Mertens,
- Joost Wauters,
- Yves Debaveye,
- Niels Van Regenmortel,
- Karlien Degezelle,
- Philippe Meersseman,
- Greet Hermans,
- Christophe Vandenbriele,
- Ruth Van Daele,
- Isabel Spriet
Affiliations
- Beatrijs Mertens
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven
- Joost Wauters
- Department of Microbiology, Immunology and Transplantation, KU Leuven
- Yves Debaveye
- Department of Cellular and Molecular Medicine, KU Leuven
- Niels Van Regenmortel
- Department of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg
- Karlien Degezelle
- Department of Perfusion Technology, University Hospitals Leuven
- Philippe Meersseman
- Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven
- Greet Hermans
- Medical Intensive Care Unit, University Hospitals Leuven
- Christophe Vandenbriele
- Department of Cardiovascular Diseases, University Hospitals Leuven
- Ruth Van Daele
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven
- Isabel Spriet
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven
- DOI
-
https://doi.org/10.1186/s13054-022-04093-y
- Journal volume & issue
-
Vol. 26,
no. 1
pp.
1
– 3
WeChat QR code
